Systemic or Endoventricular Thrombolysis to Treat HeartWare Left Ventricle Assist Device Thrombosis: A Clinical

Giuseppe M Raffa1, Giuseppe D'Ancona1, Sergio Sciacca1

  • 1Cardiac Surgery and Heart Transplantation Unit, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT), Palermo, Italy.

Artificial Organs
|March 5, 2015
PubMed

Insights

Endoventricular thrombolytic procedures (ETP) for continuous-flow left ventricle assist device (CF-LVAD) thrombosis frequently cause vascular access complications. These complications increase patient risk and healthcare costs, suggesting a need for less invasive treatments.

Area of Science:

  • Cardiovascular Surgery
  • Medical Devices
  • Interventional Cardiology

Background:

  • Continuous-flow left ventricle assist devices (CF-LVADs) are crucial for advanced heart failure treatment.
  • Pump thrombosis is a significant complication associated with CF-LVADs.
  • Endoventricular thrombolytic procedure (ETP) is a treatment option for CF-LVAD thrombosis.

Purpose of the Study:

  • To investigate the incidence and types of complications following Endoventricular thrombolytic procedures (ETP) in patients with CF-LVAD thrombosis.
  • To assess the safety and risks associated with ETP in this patient population.

Main Methods:

  • Retrospective analysis of patients who underwent CF-LVAD implantation and subsequent ETP.
  • Review of procedural data, including access routes and complications.
  • Analysis of complication rates, such as radial artery occlusion and hematomas.

Main Results:

  • Four out of 20 (20%) CF-LVAD patients developed pump thrombosis requiring ETP.
  • Nine ETPs were performed, with a high complication rate of 55.5% for vascular access.
  • Specific complications included radial artery occlusion (5 ETPs), groin hematomas (2 ETPs), and femoral artery false aneurysm (1 ETP).

Conclusions:

  • Endoventricular thrombolytic procedures (ETP) carry a substantial risk of vascular access complications in CF-LVAD patients.
  • These complications can exacerbate the existing clinical complexity and economic burden.
  • Less invasive treatment strategies for CF-LVAD thrombosis should be considered.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
473
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
709
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
610
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
623
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K